MAY 2009
VOLUME 91
NUMBER 5
COVERRed vesicular lesions with focal hemorrhage observed on theposterior aspect of the broad ligament and uterine serosalsurface (see page 1926).
MODERN TRENDS
1619 Culture of cryopreserved ovarian tissue: state of theart in 2008
R. Fabbri, G. Pasquinelli, D. Keane, B. Mozzanega,V. Magnani, F. Tamburini, and S. VenturoliBologna and Padova, Italy; and Dublin, Ireland
This is a review of the most relevant literature from thepast 10 years on the cryopreservation and culture ofovarian tissue in animals and humans.
CONTROVERSY
1630 In vitro fertilization availability and utilization in theUnited States: a study of demographic, social, andeconomic factors
A. O. Hammoud, M. Gibson, J. Stanford, G. White,D. T. Carrell, and M. PetersonSalt Lake City, Utah
There is wide discrepancy in the utilization of IVFtreatment among different US states. Lower utilizationis associated with no insurance coverage and de-creased availability of physicians who are capable ofproviding this service.
1636 Geographic distribution of reproductiveendocrinology and infertility (REI) fellowships in theUnited States
M. E. Abusief, S. A. Missmer, R. L. Barbieri, T. Jain,and M. D. HornsteinBoston, Massachusetts; and Chicago, Illinois
In the United States, the number of first-year fellow-ship positions in reproductive endocrinology and in-fertility offered through the National ResidencyMatching Program vary by geographic region, withthe fewest positions available in the West.
Copyright ª2009 American Society for Reproductive Medicine
CONTRACEPTION
1642 Does vasectomy explain the difference in tubalsterilization rates between black and white women?
S. Borrero, E. B. Schwarz, M. F. Reeves,J. E. Bost, M. D. Creinin, and S. A. IbrahimPittsburgh, Pennsylvania
Our findings indicate that the lower rates of vasec-tomy among black men do not explain the observedracial difference in tubal sterilization rates.
1646 Safety and efficacy of a single-rod etonogestrelimplant (Implanon): results from 11 internationalclinical trials
P. Darney, A. Patel, K. Rosen, L. S. Shapiro,and A. M. KaunitzSan Francisco, California; Chicago, Illinois; Roseland,New Jersey; and Jacksonville, Florida
An analysis of 942 women’s use of the single subder-mal implant contraceptive containing 68 mg of etono-gestrel (‘‘Implanon’’) for up to 4 years showed it to bea safe and highly effective contraceptive, but onewhich up to 14% of users discontinue because of ir-regular bleeding.
1654 Return to fertility after cessation of a continuous oralcontraceptive
K. Barnhart, S. Mirkin, G. Grubb, and G. ConstantinePhiladelphia and Collegeville, Pennsylvania
There was no indication of a delay in return to fertilityafter use of continuous levonorgestrel 90 mg andethinyl E2 20 mg.
ECTOPIC PREGNANCY
1657 The value of vascular endothelial growth factor,pregnancy-associated plasma protein-A, andprogesterone for early differentiation of ectopicpregnancies, normal intrauterine pregnancies, andspontaneous miscarriages
E. N. Ugurlu, G. Ozaksit, A. Karaer, E. Zulfikaroglu,A. Atalay, and M. UgurAnkara, Turkey
Vascular endothelial growth factor, pregnancy-asso-ciated plasma protein-A, and progesterone cannot dif-ferentiate ectopic pregnancies from nonectopic ones.
ENDOMETRIOSIS
1662 Endometriosis of the ureter and bladder are notassociated diseases
M. S. Abrao, J. A. Dias Jr., P. Bellelis, S. Podgaec,C. R. Bautzer, and C. GromatskyS~ao Paulo, Brazil
Endometriosis affecting the ureter is not associatedwith endometriosis of the bladder; however, it isstrongly associated with advanced American Societyfor Reproductive Medicine stages of the disease andwith retrocervical and rectum-sigmoid lesions.
1668 Iron storage is significantly increased in peritonealmacrophages of endometriosis patients andcorrelates with iron overload in peritoneal fluid
J.-C. Lousse, S. Defrere, A. Van Langendonckt, J. Gras,R. Gonzalez-Ramos, S. Colette, and J. DonnezBrussels, Belgium
Iron storage is increased in peritoneal macrophages ofendometriosis patients and correlates with iron over-load in peritoneal fluid. This accumulation could com-promise macrophage function in the peritoneal cavity.
1676 Glycodelin expression in the endometrium of healthywomen and in the eutopic and ectopic endometriumof women with endometriosis
J. Meola, D. B. Dentillo, J. C. Rosa e Silva, R. A. Ferriani,L. C. Veiga, C. C. Paro de Paz, S. Giuliatti, and L. MartelliRibeir~ao Preto, Brazil
Glycodelin down-regulation in endometriotic lesionscompared with the eutopic endometrium of endome-triosis patients and the endometrium of women with-out endometriosis may indicate alteration in normalcell differentiation, proliferation, and apoptosis.
1681 Expression of interleukin-10 in patients withadenomyosis
F. Wang, H. Li, Z. Yang, X. Du, M. Cui, and Z. WenJinan, Shandong, People’s Republic of China
Patients with adenomyosis showed immunosuppres-sion-induced expression of interleukin-10 in eutopicand ectopic endometrial cells. This could be a possibleexplanation for the ability of these cells to escape hostimmunosurveillance.
1686 Reduced expression of biomarkers associated withthe implantation window in women withendometriosis
Q. Wei, J. B. St. Clair, T. Fu, P. Stratton, andL. K. NiemanBethesda, Maryland
Compared with healthy volunteers, women with endo-metriosis had decreased expression of endometrialbiomarkers associated with implantation, glycodelin-A, osteopontin, lysophosphatidic acid receptor-3,and HOXA10.
1692 Altered expression of claudin-3 and claudin-4 inectopic endometrium of women with endometriosis
X.-Y. Pan, X. Li, Z.-P. Weng, and B. WangBeijing; Qingdao and Jinan, People’s Republic of China
In a randomized study, down-regulated expression ofclaudin-3 and claudin-4 in ectopic endometrium sug-gests that claudin-3 and claudin-4 might play a patho-genic role in the formation of endometriosis.
GENETICS
1700 A pilot study of premature ovarian senescence:I. Correlation of triple CGG repeats on the FMR1 geneto ovarian reserve parameters FSH andanti-M€ullerian hormone
N. Gleicher, A. Weghofer, and D. H. BaradNew Haven, Connecticut; Vienna, Austria; and Bronx,New York
The number of triple CGG expansion repeats on theFMR1 (fragile X) gene correlates to ovarian functionparameters, reflective of ovarian reserve.
1707 A pilot study of premature ovarian senescence:II. Different genotype and phenotype for geneticand autoimmune etiologies
N. Gleicher, A. Weghofer, and D. H. BaradNew Haven, Connecticut; Vienna, Austria; and Bronx,New York
Women with premature ovarian senescence usuallypresent with distinct genetic or autoimmune pheno-type and genotype.
INFERTILITY
1712 Impact of obesity on women’s health
M. M. Lash, and A. ArmstrongBoston, Massachuestts; and Besthesda, Maryland
Obesity impacts women’s reproductive health. Identi-fying and addressing the comorbidities associatedwith elevated body mass index and helping obese pa-tients improve their fertility potential are importantconsiderations in the medical care of an increasinglyoverweight society.
IN VITRO FERTILIZATION
1717 Impact of day 3 or day 5 embryo transfer onpregnancy rates and multiple gestations
R. Beesley, R. Robinson, A. Propst, N. Arthur, andM. RetzloffLackland Air Force Base, Texas
Blastocyst transfer resulted in fewer embryos trans-ferred and improved live-birth rates in patients 35–40years old, but it also resulted in higher twin pregnancyrates. Younger patients opting for day 5 embryo trans-fer should commit to single embryo transfer.
1721 Assisted reproductive technologies in Canada: 2005results from the Canadian Assisted ReproductiveTechnologies Register
J. Gunby, F. Bissonnette, C. Librach, L. Cowan, onbehalf of the IVF Directors Group of the CanadianFertility and Andrology SocietyBurlington and Toronto, Ontario; Montreal, Quebec;and Victoria, British Columbia, Canada
The Canadian Assisted Reproductive TechnologiesRegister compiled a report on assisted reproductivetechnologies treatments for 2005, with all 25 Canadiancenters participating. Pregnancy and birth rates con-tinued to increase in 2005 compared with previousyears.
1731 A prospective randomized controlled trial ofpreimplantation genetic screening in the ‘‘goodprognosis’’ patient
L. R. Meyer, S. Klipstein, W. D. Hazlett, T. Nasta,P. Mangan, and V. C. KarandeHoffman Estates, Illinois
In good-prognosis patients, the in vitro fertilization cy-cle outcome was not improved by screening embryosfor aneuploidy by fluorescence in situ hybridization.
1739 Follicular fluid and serum levels of Inhibin A andpregnancy-associated plasma protein A in patientsundergoing IVF
J. Moos, V. Filova, J. Pavelkova, M. Moosova,J. Peknicova, and K. RezabekPrague, Czech Republic
The observed relations between serum and follicularfluid PAPP-A and Inhibin A suggest that follicular fluidis a major source of serum Inhibin A, but not of serumPAPP-A.
1745 Damage of embryo development caused byperoxidized mineral oil and its association withalbumin in culture
J. Otsuki, Y. Nagai, and K. ChibaSaitama and Tokyo, Japan
The use of peroxidized mineral oil could damage em-bryo development. Toxicity may be related to the pres-ence of free radicals and peroxidized albumin in theculture medium.
1750 Myo-inositol may improve oocyte quality inintracytoplasmic sperm injection cycles. Aprospective, controlled, randomized trial
E. Papaleo, V. Unfer, J.-P. Baillargeon, F. Fusi, F. Occhi,and L. De SantisMilan and Rome, Italy; and Sherbrooke, Canada
In a prospective, randomized, controlled trial, myo-inositol improved oocyte quality in intracytoplasmicsperm injection cycles.
1755 Premature luteinization and in vitro fertilizationoutcome in gonadotropin/gonadotropin-releasinghormone antagonist cycles in women with polycysticovary syndrome
S. SegalI, Glatstein, P. McShane, S. Hotamisligil,D. Ezcurra, and R. CarsonLexington and Rockland, Massachusetts
Patients with PCOS undergoing controlled ovarian hy-perstimulation for IVF with gonadotropin/GnRH antag-onist who exhibited premature luteinization had moreoocytes retrieved, more mature oocytes, and similarpregnancy rates compared with those without prema-ture luteinization.
1760 Logarithmic curves depicting initial level and rise ofserum beta human chorionic gonadotropin and livedelivery outcomes with in vitro fertilization: Ananalysis of 6021 pregnancies
M. I. Shamonki, J. L. Frattarelli, P. A. Bergh, andR. T. ScottLos Angeles, California; and Morristown, New Jersey
Logarithmic curves predicting live delivery rates areestablished after analysis of data from 6021 in vitro fer-tilization pregnancies with detectable early serum betahuman chorionic gonadotropin.
1765 In vitro development and pregnancy outcomes forhuman embryos cultured in either a single medium orin a sequential media system
S. Sepulveda, J. Garcia, E. Arriaga, J. Diaz,L. Noriega-Portella, and L. Noriega-HocesLima, Peru
Embryos were cultured in a sequential media or a sin-gle culture medium. In vitro development and implan-tation rates were significantly better for embryoscultured in the single medium.
1771 Trace element concentrations in follicular fluid ofsmall follicles differ from those in blood serum, andmay represent long-term exposure
T. Silberstein, O. Saphier, O. Paz-TalL, Gonzalez,D. L. Keefe, and J. R. TrimarchiProvidence and Kingston, Rhode Island; and BeerSheva, Israel
Concentrations of elements in follicular fluid of smallfollicles can differ from those in blood serum and rep-resent longer term element exposure, whereas thoseof growing follicles are representative of the coincidentblood concentrations.
1775 The use and effectiveness of in vitro fertilization inwomen with endometriosis: the surgeon’sperspective
E. Somigliana, R. Daguati, P. Vercellini, G. Barbara,L. Benaglia, and P. G. CrosignaniMilan, Italy
In a clinical context, the proportion of infertile womenwith endometriosis who underwent in vitro fertiliza-tion was low. The technique played only a minorrole in the treatment of endometriosis-associatedinfertility.
1780 Evaluation of two incubation environments—ISOclass 8 versus ISO class 5—on intracytoplasmicsperm injection cycle outcome
M. C. B. Souza, A. C. A. Mancebo, C. A. da Rocha,C. A. Henriques, M. M. Souza, and F. F. O. CardosoRio de Janeiro, Brazil
Incubation environment on intracytoplasmic sperminjection (ICSI) outcome was studied in 123 consec-utive ICSI cycles: 60 in class 8 air quality and 63 inclass 5. The outcomes were not statistically signifi-cantly different.
MALE FACTOR
1785 Coenzyme Q10 treatment in infertile men withidiopathic asthenozoospermia: a placebo-controlled,double-blind randomized trial
G. Balercia, E. Buldreghini, A. Vignini, L. Tiano,F. Paggi, S. Amoroso, G. Ricciardo-Lamonica,M. Boscaro, A. Lenzi, and G. P. LittarruAncona and Rome, Italy
Coenzyme Q10 and ubiquinol concentrations in-creased and sperm motility improved significantly,with a linear positive dependence, in semen of infertilemen after 6 months of exogenous administration.
1793 The impact of hemochromatosis mutations andtransferrin genotype on gonadotropin serum levels ininfertile men
A. Buretic-TomljanovicI, Vlastelic, A. Radoj�cic,Badovinac, N. Star�cevic-�Cizmarevic, S. Nadalin,and S. RisticRijeka, Croatia
Hemochromatosis mutation H63D and transferrin C2allele influence the hypothalamic-pituitary-gonadalaxis at the pituitary and/or testes level and affectmale fertility status, causing increase in serumgonadotropin values above the normal physiologicrange.
1801 Correlation between DNA damage and spermparameters: a prospective study of 1,633 patients
P. Cohen-Bacrie, S. Belloc, Y. J. R. M�en�ezo, P. Clement,J. Hamidi, and M. BenkhalifaParis, Le Blanc Mesnil, and La Verriere, France
One third of patients had a terminal deoxyribonucleo-tidyl transferase–mediated dUTP nick-end labeling(TUNEL) rate of >30%, and analysis of the 21 semenparameters tested revealed that 7 of these parameterswere significantly correlated with the TUNEL results.World Health Organization sperm parameters andDNA damage are complementary, rather than stronglylinked.
1806 Combined use of phosphodiesterase-5 inhibitors andselective serotonin reuptake inhibitors for temporaryejaculation failure in couple undergoing assistedreproductive technologies
S. Lu, Y. Zhao, J. Hu, X. Li, H. Zhang, L. You, andZ.-j. ChenJinan, Shandong, People’s Republic of China
Five men with unexpected ejaculation failure duringassisted reproductive technologies were treated withphosphodiesterase-5 inhibitors and selective seroto-nin reuptake inhibitor and succeeded in collectingsperm samples.
1809 Impact of a second semen analysis on a treatmentdecision making in the infertile man with varicocele
A. Mishail, S. Marshall, D. Schulsinger, andY. SheynkinStony Brook, New York
In most infertile men with palpable varicocele and firstabnormal SA, the second SA is also abnormal anddoes not change treatment decision.
1812 Anti-M€ullerian hormone in men with normal andreduced sperm concentration and men withmaldescended testes
F. T€uttelmann, N. Dykstra, A. P. N. Themmen,J. A. Visser, E. Nieschlag, and M. SimoniM€unster, Germany; and Rotterdam, The Netherlands
Anti-M€ullerian hormone serum levels are not signifi-cantly affected by impaired spermatogenesis ingeneral but are correlated with spermatogenic param-eters in men with current or former maldescendedtestes.
OVULATION INDUCTION
1820 Differences in gene expression of granulosa cellsfrom women undergoing controlled ovarianhyperstimulation with either recombinant follicle-stimulating hormone or highly purified humanmenopausal gonadotropin
M. L. Grøndahl, R. Borup, Y. B. Lee, V. Myrhøj,H. Meinertz, and S. SørensenHvidovre and Copenhagen, Denmark
Statistically significant differences in the gene expres-sion profile (i.e., luteinizing hormone/human chorionicgonadotropin receptor) of preovulatory granulosa cellsare present after controlled ovarian hyperstimulationinduced by recombinant follicle-stimulating hormone(FSH) and urinary derived FSH, respectively.
1831 Follicular and endocrine response to anastrozoleversus clomiphene citrate administered in follicularphase to normoovulatory women: a randomizedcomparison
G. Griesinger, S. von Otte, A. Schultze-Mosgau,K. Diedrich, and A. Schr€oerLuebeck, Germany
Clomiphene citrate 50 mg administered from cycledays 3 to 7 to normoovulatory women stimulatesgrowth of a larger cohort of follicles and results inhigher area under the curve levels for serum E2
compared with anastrozole in doses of 1 or 5 mg,respectively.
1837 Recombinant luteinizing hormone induces increasedproduction of ovarian follicular adiponectin in vivo:implications for enhanced insulin sensitivity
G. Gutman, V. Barak, S. Maslovitz, A. Amit,J. B. Lessing, and E. GevaTel Aviv and Jerusalem, Israel
Recombinant LH induces increased production ofovarian follicular adiponectin. The addition of recombi-nant LH during ovulation induction may play a role inoptimizing the metabolic/endocrine milieu during folli-culogenesis and ovulation.
1842 Cetrorelix protocol versus gonadotropin-releasinghormone analog suppression long protocol forsuperovulation in intracytoplasmic sperm injectionpatients older than 40
M. Sbracia, J. Colabianchi, A. Giallonardo, P. Giannini,C. Piscitelli, F. Morgia, M. Montigiani, andM. SchimberniRome, Italy
In patients >40 years old who are undergoing in vitrofertilization, controlled ovarian hyperstimulation withthe long protocol works better than with the cetrorelixprotocol.
POLYCYSTIC OVARY SYNDROME
1848 Dehydroepiandrosterone sulfate and insulinresistance in patients with polycystic ovary syndrome
K. Brennan, A. Huang, and R. AzzizLos Angeles, California
Dehydroepiandrosterone sulfate is negatively corre-lated to insulin resistance in patients with PCOS. Theadrenals and ovaries, age, and body fat, togetherdetermine the degree of insulin resistance in PCOS.
1853 Influence of sociocultural factors on the ovulatorystatus of polycystic ovary syndrome
G. Di Fede, P. Mansueto, R. A. Longo, G. B. Rini,and E. CarminaPalermo, Italy
The ovulatory form of polycystic ovary syndrome wasmore common in higher social classes, and it corre-lated with a lower prevalence of abdominal obesityand insulin resistance.
1857 Suppression and recovery of gonadotropin andsteroid secretion by a gonadotropin-releasinghormone receptor antagonist in healthy women withnormal ovulation versus women with polycystic ovarysyndrome in the early follicular phase
F. Sagnella, R. Apa, M. Guido, P. Villa, V. Spadoni,F. Miceli, and A. LanzoneRome and Troina, Italy
Gonadotropin and androgen suppression by GnRHantagonist is more effective in patients with PCOSthan in controls, suggesting a higher sensitivity ofGnRH receptors in these patients.
1864 Prevalence of insulin resistance and determination ofrisk factors for glucose intolerance in polycysticovary syndrome: a cross-sectional study of Chineseinfertility patients
H.-J. Wei, R. Young, I.-L. Kuo, C.-M. Liaw,H.-S. Chiang, and C.-Y. YehTaipei, Taiwan
Chinese women with PCOS are at increased risk for in-sulin resistance and glucose intolerance comparedwith controls, though absolute rates are lower than inother racial groups.
1869 Association of the L243 A/G polymorphism of theglutamate decarboxylase 2 gene with obesity in girlswith premature pubarche
S. F. Witchel, C. White, and I. LibmanPittsburgh, Pennsylvania
Body mass index was greater at presentation and dur-ing the peripubertal period for girls who had at leastone allele that carried the (�243 A/G) variant of theGAD2 gene.
PREGNANCY
1877 Ibuprofen and paracetamol for pain relief duringmedical abortion: a double-blind randomizedcontrolled study
A. Livshits, R. Machtinger, L. B. David, M. Spira,A. Moshe-Zahav, and D. S. SeidmanTel Hashomer, Israel
In a prospective double-blind controlled study, ibupro-fen was more effective for pain reduction during med-ical abortion, compared with the case of paracetamol,without interfering with the action of misoprostol.
1881 Medical treatment with misoprostol for early failureof pregnancies after assisted reproductivetechnology: a promising treatment option
R. Machtinger, D. Stockheim, D. S. Seidman,L. Lerner-Geva, J. Dor, E. Schiff, and A. ShulmanTel Aviv, Israel
In a prospective study, medical treatment of missedabortions with misoprostol was found very efficient inpatients with low gravidity and in patients who con-ceived after assisted reproductive technology.
1886 Pregnancy outcomes in unicornuate uteri: a review
D. Reichman, M. R. Laufer, and B. K. RobinsonBoston, Massachusetts
The unicornuate uterus is a M}ullerian anomaly with ad-verse prognostic implications for pregnancy. Thismanuscript examines the preexisting literature onpregnancy outcomes in patients with unicornuate uteriin an attempt to create a better counseling frameworkfor such patients.
1895 Risk analysis of torsion and malignancy for adnexalmasses during pregnancy
C.-F. Yen, S.-L. Lin, W. Murk, C.-J. Wang, C.-L. Lee,Y.-K. Soong, and A. AriciTao-Yuan and Taipei, Taiwan; and New Haven,Connecticut
Adnexal tumors bearing higher risks for torsion andmalignancy should be strongly considered for an ag-gressive strategy of management during pregnancy.
RECURRENT PREGNANCY LOSS
1903 Tumor necrosis factor a and lymphotoxina haplotypes in idiopathic recurrent pregnancy loss
W. Zammiti, N. Mtiraoui, R. R. Finan, W. Y. Almawi,and T. MahjoubMonastir, Tunisia; Beirut, Lebanon; and Manama, Bahrain
Tumor necrosis factor (TNF) a [�238G/A, �308G/A]and lymphotoxin (LT) a [þ252A/G] single-nucleotidepolymorphisms were investigated in 372 recurrentmiscarriage (RM) women and 274 control women.Specific TNFa�308/TNFa�238/LTaþ252 haplotypeswere identified, and these polymorphisms were asso-ciated with exclusively early RM.
REPRODUCTIVE SURGERY
1909 Gonadotropin-releasing hormone agonistpretreatment did not decrease postoperativeadhesion formation after abdominal myomectomyin a randomized control trial
C. C. Coddington, D. R. Grow, M. S. Ahmed, J. P. Toner,E. Cook, and M. P. DiamondRochester, Minnesota; Norfolk, Virginia; Springfieldand Amherst, Massachusetts; and Detroit, Michigan
Gonadotropin-releasing hormone agonist treatment inrandomized trial before abdominal myomectomy didnot decrease postoperative adhesions. Adhesions in-creased with increasing incision length and number,and by number of fibroids removed.
1914 Sexual and organ function in patients withsymptomatic prolapse: are pessaries helpful?
A. Kuhn, D. Bapst, W. Stadlmayr, K. Vits, andM. D. MuellerBerne, Switzerland; and Southampton, United Kingdom
This study demonstrated that cube pessaries are a vi-able treatment for pelvic organ prolapse, improvingpelvic organ organ symptoms and sexual function. In-ability to retain pessaries and de novo stress inconti-nence limit their use.
UTERINE FIBROIDS
1919 Vitamin D inhibits myometrial and leiomyoma cellproliferation in vitro
M. Bl€auer, P. H. Rovio, T. Ylikomi, and P. K. HeinonenTampere, Finland
Both myometrial and leiomyoma cell growth in vitrowas effectively inhibited by 1,25(OH)2D3. Vitamin Dmay play a role in the growth of uterine leiomyomas.
IMAGES IN REPRODUCTIVE MEDICINE
1926 Menstrual bleeding from an endometriotic lesion
R. O. Burney, and R. B. LathiStanford, California
We present a case in which endometriotic lesions wereobserved to be focally hemorrhagic at laparoscopyperformed during menstruation. Red vesicular lesionslikely represent early disease with intact capacity forhormonally induced menstrual bleeding.
TECHNIQUES AND INSTRUMENTATION
1928 Long-term liquid nitrogen vapor storage of mouseembryos cryopreserved using vitrification or slowcooling
J. H. Eum, J. K. Park, W. S. Lee, K. R. Cha, T. K. Yoon,and D. R. LeeSeoul, South Korea
Long-term storage of cryopreserved mouse embryosin liquid nitrogen vapor is a safe and effective methodfor preventing disease transmission via liquid nitrogen.
1933 Laparoscopic cornuotomy using a temporarytourniquet suture and diluted vasopressin injection ininterstitial pregnancy
Y.-S. Choi, D.-S. Eun, J. Choi, K.-S. Shin, J.-H. Choi,and H.-D. ParkKwang-ju, South Korea
Laparoscopic cornuotomy using temporary tourniquetsuture is a safe and effective method, and we believethat it has an advantage of preserving reproductive ca-pacity in interstitial pregnancy.
1938 Pregnancy after trophectoderm biopsy of frozen–thawed blastocyst
R. B. Lathi, and B. BehrStanford, California
Trophectoderm biopsy for preimplantation genetictesting is an emerging technique for fresh embryos.We report the first pregnancy resulting from this tech-nique applied to cryopreserved blastocysts.
1941 Advantage of conservative surgical managementof large ovarian neoplasms in adolescents
J. Reddy, and M. R. LauferBoston, Massachusetts
After cystectomy for a large ovarian neoplasm, the af-fected ovary resumes its normal size and volume, de-spite the attenuated appearance of the ovarian cortexat the time of surgery.
1945 Comparison of ultraminilaparotomy for myomectomythrough midline vertical incision or modifiedPfannenstiel incision—a prospective short-termfollow-up
P.-H. Wang, W.-M. Liu, J.-L. Fuh, H.-T. Chao,C.-C. Yuan, and K.-C. ChaoTaipei, Taiwan
Ultraminilaparotomy (UMLT), either through a midlinevertical incision (MVI) or a modified Pfannenstiel inci-sion (MPI), is a feasible minimal-access option in themanagement of uncomplicated uterine myomas, butthe MPI operation might be more complicated.
1951 Prophylactic intraoperative uterine arteryembolization to control hemorrhage in abnormalplacentation during late gestation
P.-C. Yu, H.-Y. OuL, Leung-Chit Tsang, F.-T. Kung,T.-Y. Hsu, and Y.-F. ChengKaohsiung, Taiwan
In cases of placenta accreta, increta, and percreta,prophylactic, intraoperative uterine artery emboliza-tion before placental removal provides for excellenthemostasis, decreased morbidity and mortality,and an increased chance of preservation of theuterus.
CASE REPORT SUMMARIES
1956 Successful pregnancy and delivery of a healthy babyafter endometrial biopsy treatment in an in vitrofertilization patient with severe Asherman syndrome
A. Barash, I. Granot, S. Fieldust, and Y. OrRehovot, Israel
Endometrial biopsy, a procedure known to increaseendometrial receptivity in IVF patients with repeatedimplantation failures, is shown as a successful supple-mentary treatment in a patient with Ashermansyndrome.
1956 Delayed delivery following unusual flare-up pelvicabscess after in vitro fertilization and embryo transfer
K. Biringer, P. Zubor, J. Visnovsky, and J. DankoMartin, Slovak Republic
A case report of delayed interval delivery following pel-vic abscess, which required laparotomy after uncom-plicated IVF-ET. According to accessible articles, weare the first to report such a case.
1956 Multiple extrauterine adenomyomas and uterus-likemasses: case reports and review of the literature
S. Carinelli, F. Motta, G. Frontino, E. Restelli, andL. FedeleMilan, Italy
Two rare cases of multiple extrauterine adenomyosisof probable metaplastic origin were effectively con-trolled with long-term gonadotropin-releasing hor-mone agonist therapy.
1956 Thrombosis post ovarian hyperstimulation
S. E. Chipwete, S. Bugren, and N. RaflaMargate, United Kingdom
Case of a 37-year-old lady who presented with internaljugular and subclavian vein thrombosis following ovar-ian hyperstimulation syndrome while on prophylacticheparin. She was successfully treated with low molec-ular weight heparin, and had a live birth at term.
1956 Live birth of a normal mature healthy baby by in vitrofertilization–embryo transfer (IVF-ET) after anexploratory laparotomy and multiple myomectomyfor leiomyomatosis peritonealis disseminata
S. L. DeAngelis, R. R. Harris, M. A. Maiman,and E. S. KnochenhauerStaten Island, New York
In vitro fertilization–embryo transfer can produce a nor-mal healthy baby in a patient with leiomyomatosis peri-tonealis disseminata. Leiomyomatosis peritonealisdisseminata does not require immediate hysterectomyin a woman who desires future childbearing.
1957 Bilateral epididymal sarcoidosis
A. Hassan, S. El-Mogy, K. Zalata, and T. MostafaMansoura and Cairo, Egypt
We report an azoospermic 29 year old Caucasian malewith past history of painless subcutaneous nodules.He had bilateral epididymal firm masses with enlargedfirm non-painful inguinal lymph nodes. Scrotal USshowed diffuse bilateral epididymal enlargement withheterogeneous echo pattern and increased vascular-ity. Scrotal MRI revealed no focal masses. Chest Xray revealed hilar shadows and chest CT revealed me-diastinal and hilar lymphadenopathy. Urine and semenZeihl-Neelsen stain were negative for acid-fast bacilli.Epididymal histopathology revealed multiple non-caseating epithelioid granulomas with concentric ar-rangement of reticular fibers. The diagnosis was bilat-eral epididymal sarcoidosis.
1957 Uterine conservation despite severe sepsis in a caseof placenta accreta first treated conservatively:3-month delayed successful removal of the placenta
O. Morel, P. Desfeux, Y. Fargeaudou, C. Malartic,M. Rossignol, C. Perrotez, and E. BarrangerParis, France
In cases of delayed sepsis after conservative treat-ment for placenta accreta, when medical treatment re-mains unsuccessful, manual removal of the placentashould be attempted.
1957 VATER/VACTERL syndrome (vertebra/anus/cardiac/trachea/esophogus/radius/renal/limb anomalies)with a noncommunicating functioning uterine hornand a unicornuate uterus: a case report
N. Nunes, S. Karandikar, S. Cooper, R. Jaganathan,and S. IraniBirmingham, United Kingdom
This is a case report of a patient in whom VATER/VAC-TERL syndrome coexisted with a unicornuate uterusand a noncommunicating functioning rudimentaryhorn who presented with severe constipation and uri-nary retention.
1957 Horizontal uterine torsion in the setting of completecervical and partial vaginal agenesis: a case report
K. Omurtag, D. Session, P. Brahma, A. Matlack,and C. RobertsAtlanta, Georgia
A 13-year-old female adolescent with pelvic pain andamenorrhea with partial vaginal and complete cervicalagenesis, and horizontal uterine torsion is described.
1957 Mucocele of the appendix causing tubal factorinfertility
M. L. Traub, D. S. Lee, P. B. Paty, and H. LiemanBronx and New York, New York
Mucinous cystadenoma of the appendix and pseudo-myxoma peritonei in a young woman desiring futurechildbirth can be managed conservatively. Childbirth,even after IVF, can be accomplished safely.
1958 Triplet pregnancy and successful twin delivery ina patient with congenital cervical atresia whounderwent transmyometrial embryo transfer andmultifetal pregnancy reduction
C. Xu, J. Xu, H. Gao, and H. HuangHangzhou, Zhejiang, People’s Republic of China
The patient with endometriosis-associated and tubalfactor infertility who underwent uterovaginal canaliza-tion surgery 9 years ago for congenital cervical atresiaachieved a successful triplet pregnancy and healthytwin birth after in vitro fertilization and transmyometrialembryo transfer followed by multifetal pregnancyreduction.
1958 Preimplantation genetic diagnosis for X-linkedagammaglobulinemia: a case report
C. Xu, B. Xu, H. Huang, X. Huang, and F. JinHangzhou and Zhejiang, People’s Republic of China
We report the first case of PGD for X-linked agamma-globulinemia caused by a point mutation in Bruton’styrosine kinase gene. The result indicates that PGD isfeasible for this disease.
CORRESPONDENCE
1959 Zona-free versus laser zona-assisted hatchingblastocyst transfer: a comparison of outcomes
K.-C. Lan, F.-J. Huang, Y.-C. Lin, F.-T. Kung,and S. Y. ChangHangzhou and Zhejiang, People’s Republic of ChinaIn unselected IVF patients, zona-free and laser zona-assisted hatching produced a comparable effect onblastocyst transfer.
1963 Oral contraceptive pretreatment in womenundergoing controlled ovarian stimulation inganirelix acetate cycles may, for a subset of patients,be associated with low serum luteinizing hormonelevels, reduced ovarian response to gonadotropins,and early pregnancy loss
D. R. Meldrum, R. T. Scott Jr., M. J. Levy, M. M. Alper,and N. NoyesRedondo Beach, California; Morristown, New Jersey;Rockville, Maryland; Waltham, Massachusetts; andNew York, New York
Oral contraceptive scheduling of controlled ovarianhyperstimulation–GnRH antagonist cycles was asso-ciated, in a small subset of patients, with low serumLH levels, reduced ovarian response, and early preg-nancy loss.
LETTERS TO THE EDITOR
e1 Help me understand what you are saying about lutealphase support for in vitro fertilization
P. W. ZarutskieLaguna Niguel, California
e2 – Reply: K. J. Doody, V. L. Schnell, R. A. Foulk,C. E. Miller, B. A. Kolb, E. J. Blake, and V. I. Yankov
Bedford and Webster, Texas; Reno, Nevada; ArlingtonHeights, Illinois; Pasadena, California; and Parsippany,New Jersey
e3 Use of phosphodiesterase type 3 inhibitor to improveIVM outcome: experimental set up matters
D. Nogueira, and L. VanhoutteToulouse, France; and Ghent, Belgium
e4 – Reply: B. C. Jee, H.-Y. Chen, and R.-C. Chian
Seongnam, Korea; and Quebec, Canada
e6 Kabuki syndrome and sex chromosomal anomalies:is it really an association?
S. Bianca, B. Barrano, A. Cataliotti, L. Indaco,C. Ingegnosi, and G. EttoreCatania, Italy
e7 Xenografting fresh and cryopreserved human ovariantissue
O. Oktem, and B. UrmanIstanbul, Turkey
e9 – Reply: B. Schubert, M. Canis, C. Darcha, C. Artonne,J. Smitz, and G. Grizard
Clermont-Ferrand, France; and Brussels, Belgium
e10 Hysteroscopic resection of the uterine septum: is italways a necessity?
F. B. CebesoyGaziantep, Turkey
e11 – Reply: A. Mollo, C. Alviggi, G. De Placido,P. De Franciscis, L. Cobellis, N. Colacurci, A. Perino,and R. Venezia
Naples and Palermo, Italy
e12 Beyond consanguinity risk: developing donor birthlimits that consider psychosocial risk factors
J. E. Scheib, and A. RubyDavis and Berkeley, California
e13 – Reply: N. Sawyer
Victoria, Australia
e14 Dehydroepiandrosterone treatment of ovarian failure
D. H. Barad, A. Weghofer, and N. GleicherNew York, New York
e15 – Reply: L. Mamas, and E. Mamas
Athens, Greece
e16 Less may, indeed, be less: multicollinearity instudies of ovarian reserve
D. H. Barad, and N. GleicherNew York, New York
e17 – Reply: L. Pal, S. Jindal, B. R. Witt, and N. F. Santoro
The Bronx, New York
e19 Correlation between DNA damage and spermparameters
F. F. Verit, and A. VeritSanliurfa, Turkey
e20 – Reply: P. C. Bacrie, and Y. Menezo
La Verriere, France
e21 Evidence of absence or absence of evidence? Areanalysis of the effects of low-dose aspirin in in vitrofertilization
T. A. Gelbaya, and L. G. NardoManchester, United Kingdom
e22 – Reply: E. F. Schisterman, and B. W. Whitcomb,M. Ruopp
Bethesda, Maryland
e23 Flow-mediated dilatation in polycystic ovarysyndrome women
W. P. Martins, C. O. Nastri, C. S. Vieira, andR. A. FerrianiRibeir~ao Preto, Brazil
e24 – Reply: S. Arikan, H. Akay, M. Bahceci, A. Tuzcu,and D. Gokalp
Diyarbakir, Turkey
e25 Setting up a medical abortion service for failure
Y. Swica, and B. WinikoffNew York, New York
e26 – Reply: D. S. Seidman
Tel-Hashomer, Israel
e27 Protein Z levels and recurrent pregnancy loss
S. Effraimidou, D. Farmakiotis, and M. TopalidouThessaloniki, Greece
e28 – Reply: A. Dossenbach-Glaninger, and P. Hopmeier
Vienna, Austria
e29 Generational amnesia
M. G. MunroLos Angeles, California
e30 – Reply: S. Deb
Nottingham, England
e31 Cardiovascular risks of pregnancy in women withTurner syndrome
C. Bondy, D. Rosing, R. ReindollarBethesda, Maryland; and Lebanon, New Hampshire
e33 Susceptibility to aortic dissection in TurnerSyndrome pregnancy: inadequacy of the ASRMPractice Committee Report
M. SilberbachPortland, Oregon
e34 – Reply: C. C. Boissonnas, P. Jouannet, C. Davy,and L. Cabanes
Paris, France
e35 CA-125 as a biomarker for malignant transformationof endometriosis
J. H. CheckCamden, New Jersey
e36 – Reply: F. Nezhat
New York, New York
e37 The endometriosis–ovarian cancer connection: thecase against preventive surgery
P. Vercellini, F. Parazzini, E. Somigliana, P. Vigano,G. Bolis, and L. FedeleMilan, Italy
e38 Modified ultrasound scanning is a cost-effectivemethod for the detection of deep infiltratingendometriosis
S. Guerriero, J. L. Alcazar, S. Ajossa, and G. B. MelisCagliari, Italy; and Pamplona, Spain
e39 – Reply: M. Bazot, E. Daraı
Paris, France
e40 Good News for Women with Endometriosis!
H. RomanRouen, France
e41 – Reply: R. Seracchioli
Bologna, Italy
BOOK REVIEW
1966 Review of Oncofertility: Fertility Preservation forCancer Survivors, edited by T. K. Woodruffand S. K. Ann
J. RobinsProvidence, Rhode Island
CLASSIFIED ANNOUNCEMENTS
23A Classified Announcements
: Article is only available online
: Complete article available online
Visit www.fertstert.org for e-only ande-extra materials
Complete instructions for authors may befound in the June and December issues of thejournal and at the journal’s website, http://www.fertstert.org
All clinical trials that begin afterJanuary 1, 2008, must show proof ofregistration with the ProtocolRegistration System (http://prsinfo.clinicaltrials.gov), a public trialsregistry provided by the NationalInstitutes of Health. Fertility andSterility will not consider forpublication reports of unregisteredtrials which were begun after that date.